A Network Meta-Analysis of Success Rates following Low Dosage Anti-VEGF for Retinopathy of Prematurity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Network Meta-Analysis of Success Rates following Low Dosage Anti-VEGF for Retinopathy of Prematurity

Published:2023-09-28 Issue:1 Volume:49 Page:1-9
ISSN:0271-3683
Container-title:Current Eye Research
language:en
Short-container-title:Current Eye Research

Author:

Zhuang Hua¹,Lin Lin²,Luo Danling¹,Zheng Ning-Xuan³

Affiliation:

1. Department of Ophthalmology, Maternal and Child Health Hospital of Xianyou County, Putian, China

2. Department of Ophthalmology, Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, China

3. Fujian Center for Disease Control and Prevention, Fuzhou, China

Publisher

Informa UK Limited

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02713683.2023.2259628

Reference50 articles.

1. THE CUTTING EDGE OF RETINOPATHY OF PREMATURITY CARE

2. Management of retinopathy of prematurity–use of anti-VEGF therapy;Tran KD;Asia Pac J Ophthalmol,2018

3. Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity

4. Global Disparities in Retinopathy of Prematurity: A Literature Review

5. The role of anti-vascular endothelial growth factor in treatment of retinopathy of prematurity—a current review

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP